Insider Selling: Jerald L. Pullins Sells 3,000 Shares of U.S. Physical Therapy Stock (USPH)
U.S. Physical Therapy (NASDAQ:USPH) Director Jerald L. Pullins unloaded 3,000 shares of the stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $35.46, for a total value of $106,380.00. Following the completion of the transaction, the director now directly owns 32,846 shares in the company, valued at approximately $1,164,719. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
U.S. Physical Therapy (NASDAQ:USPH) traded up 0.01% during mid-day trading on Wednesday, hitting $35.635. The stock had a trading volume of 10,154 shares. U.S. Physical Therapy has a one year low of $27.80 and a one year high of $37.25. The stock has a 50-day moving average of $35.33 and a 200-day moving average of $33.36. The company has a market cap of $436.0 million and a price-to-earnings ratio of 32.04.
U.S. Physical Therapy (NASDAQ:USPH) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.08. The company had revenue of $66.90 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Analysts expect that U.S. Physical Therapy will post $1.70 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 5th. Shareholders of record on Monday, August 18th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 14th.
Separately, analysts at Jefferies Group raised their price target on shares of U.S. Physical Therapy from $38.00 to $40.00 in a research note on Friday, August 8th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. U.S. Physical Therapy currently has an average rating of “Buy” and a consensus price target of $36.80.
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.